News

[ad_1] The post Nio Stock Briefly Jumps on Soaring Vehicle Deliveries appeared first on Millennial Money. Shares of Nio (NYSE: NIO) briefly jumped on Thursday morning after the Chinese electric vehicle (EV) company reported monthly vehicle deliveries. Shipment volumes soared in the month of June as the global semiconductor shortage eased, allowing Nio to manufacture more cars to meet demand. The stock had gained as much as 4% in early trading, but shifted into reverse and ended up down by 2% as of 12 p.m. EDT. Here’s what EV investors need to know about Nio’s second quarter figures. Q2 deliveries came in near the high end of guidance Total vehicle deliveries in June soared 116% to 8,083. That brought volumes for the second quarter to 21,896, an increase of 112% from a year ago and near the high end of the company’s guidance range of 21,000 to 22,000 vehicles.  Here’s a breakdown of the models Nio sold. Model Deliveries ES8 1,498 ES6 3,755 EC6 2,830 Total 8,083 Data source: Nio The ES8 is Nio’s flagship premium SUV that can seat six to seven passengers, while the ES6 is a smaller SUV that emphasizes performance. The EC6 is a more compact coupe SUV. This was the first time Nio has delivered more than 8,000 vehicles in a month, which was made possible as chip shortage challenges faded into the rearview mirror. Deliveries have been improving sequentially each month as the supply chain conditions improve. Month Deliveries April 7,102 May 6,711 June 8,083 Total 21,896 Data source: Nio “Our order momentum remains solid, while the risk of a global chip shortage still looms large in the second quarter,” CEO William Li had previously said on the earnings call in April (through a translator).  As of the end of June, Nio’s cumulative deliveries had reached 117,597 total vehicles throughout its history. The road ahead While the delivery numbers were strong and underscore the underlying demand trends in China’s booming EV market, the modest drop in the stock may be attributable to the fact that shares climbed 6% yesterday after Citi boosted its price target on Nio to $72. Investors were already pricing in lofty growth expectations. Analyst Jeff Chung was predicting “robust shipment volumes” in the second quarter, and Nio delivered. The analyst was modeling for 21,200 deliveries in the second quarter. Nio has not formally scheduled its second quarter earnings release yet, but typically reports its quarterly results in August. The company’s guidance calls for revenue in the range of 8.15 billion yuan to 8.5 billion yuan, or $1.26 billion to $1.31 billion based on current exchange rates. That would represent top line growth of 119% to 129% compared to the second quarter of 2020. Pick Like A Pro Where to invest $500 right now Lots of new investors take chances on long shots instead of buying shares of great companies. I prefer businesses like Amazon, Netflix, and Apple — they’re all on my best stocks for beginners list. There’s a company that “called” these businesses long before they hit it big. They first recommended Netflix in 2004 at $1.85 per share, Amazon in 2002 at $15.31 per share, and Apple back in the iPod Shuffle era at $4.97 per share. Take a look where they are now. That company: The Motley Fool. For people ready to make investing part of their strategy for financial freedom, take a look at The Motley Fool’s flagship investing service, Stock Advisor. They just announced their top 10 “best buys now” across the entire stock market. Whether you’re starting with $100, $500, or more, you should check out the full details. Email Address Continue Also opt-in to receive Millennial Money! It’s our newsletter devoted to helping you achieve financial freedom. That means you’ll receive new stock ideas, our favorite side hustles, and much more every single week! By submitting your email address, you consent to us keeping you informed about updates to our website and about other products and services that we think might interest you. You can unsubscribe at any time. Please read our Privacy Statement and Terms & Conditions. window.onload = function(event) { if (!document.getElementById(‘ecap-async-js’)) { dataLayer.push({‘event’ : ‘ctaFailed’, ‘failType’ : ‘JS Enqueue Failure’ }); } } Click here to learn more .tmfsa-text-widget .ecap-widget { padding: 0 !important; border-left: 0 !important; } The post Nio Stock Briefly Jumps on Soaring Vehicle Deliveries appeared first on Millennial Money. [ad_2] Source link

[ad_1] Wanting to hang some pictures on your wall? This is a fantastic deal on canvas photo prints! Wow! Right now, Simple Canvas Prints is offering our readers HUGE savings on Canvas Photo Prints! There are many sizes to choose from and you can get up to 95% off! Plus, shipping is free on orders over $20. As a deal idea, you can get these 8×8 professional-quality photo canvas prints for just $8 each. Order three of these prints and you’ll pay just $24 shipped total! Here’s how to get this deal: Buy three 8×8 Canvas Prints – $8 each for our readers (regularly $158.75)Shipping is free on orders over $20Just $24 shipped total for all three I ordered four of these Canvas Photo Prints a few months ago and was extremely surprised by the quality. They made the perfect picture collage of my kids in the hallway. These would make great gift ideas! [ad_2] Source link

[ad_1] Canada Day muted as country reckons with treatment of indigenous, other minorities [ad_2] Source link

[ad_1] CIL’s April-June off-take was also close to 7 MTs higher at around 160 MTs, clocking a 4.5% growth compared to the April-June quarter in FY20 when the country was yet to get affected by Covid-19. [ad_2] Source link

[ad_1] Home values have increased over the past several months and consumers are realizing there is more equity in their homes than anticipated. This realization has increased demand for wholesale lenders and brokers as borrowers look to refinance, cash-out refinance or otherwise take advantage of the equity in their homes. The right mortgage services provider is essential to helping wholesale lenders and their brokers thrive in this constantly evolving market.  ServiceLink, which is backed by Fidelity National Financial, meets the unique needs of wholesale lenders by providing title insurance, appraisals, flood certificates and closing services. Regardless of the lenders’ size, ServiceLink’s exclusive EXOS technology, comprehensive industry experience, and stability help lenders get to closing quickly while providing a better borrower experience. Our nationwide footprint paired with an expansive pool of vendors makes ServiceLink a reliable wholesale partner.  “We provide title and closing services in all 50 states, and the broker works with the exact same client service team,” ServiceLink client relationship executive Nicole Blosch said. “The broker knows they will get the same turn times and the same service levels regardless of the property’s location.” More than 50 years of title industry expertise gives ServiceLink unique insight into the needs of our wholesale clients. Our EXOS Title technology offers accelerated title decisioning and a definitive clear-to-close timeline in seconds. ServiceLink combines that cutting-edge technology with hands-on customer service, proactive reporting to help with pipeline management, and a deep understanding of brokers’ processes and requirements.   “Brokers hate surprises. At ServiceLink, we have a commitment to constant communication to make sure brokers are updated throughout the lifecycle of an order,” said Brian Pidgeon, vice president, national sales executive, ServiceLink. ServiceLink continues to combine technology and service into the closing process. Once a file is cleared to close, brokers and borrowers can schedule the closing appointments – virtual, in-person, or hybrid – with EXOS Close. With EXOS Close, brokers are connected with the exact, real-time availability of local signing agents and can instantly schedule a closing appointment for the date and time of their choice. ServiceLink’s expansive notary network means we have vendors ready and waiting to complete closings, even during high-volume periods.  ServiceLink’s unique tech-enabled mortgage services include valuations as well. We have a valuations team solely dedicated to the wholesale market, whose dedicated hands-on approach ensures milestones and commitments are met. In addition to a website for ordering, including safe and secure credit card payment, real-time scheduling through EXOS Valuations drives efficiencies. With EXOS Valuations, brokers and borrowers schedule with the industry’s largest appraiser network – which has local market expertise and a history of superior valuation service. Clients are able to quickly schedule their appraisal inspection, without phone tag or other scheduling delays.   “The future of wholesale lending is a continued use of technology and innovation to help further streamline the lending process,” Pidgeon said. “ServiceLink is focused on developing more real-time transparency into the appraisal experience, as well as improvements in the appraisal inspection process by capturing more information including video, geocoding, digital sketches — all using mobile devices.” As the nation emerges from this historic rate market and the purchase market continues to boom, wholesale lenders will continue to experience high volume. No matter what’s next for the industry, ServiceLink’s nationwide suite of mortgage services will continue to help lenders and their brokers efficiently manage their volume and provide a differentiated customer experience.  Brian Pidgeon, Vice President  Brian Pidgeon has a 14-year career focused on valuations with ServiceLink and now serves as vice president and national sales executive.  Nicole Blosch, Client Relationship Executive  Nicole Blosch backs her role as client relationship executive with ServiceLink with more than 20 years in both lending and title. The post ServiceLink offers brokers constant communication and transparency into valuation and closing appeared first on HousingWire. [ad_2] Source link

[ad_1] The post Top Biotech Stocks for 2021: These Seven Biotechnology Companies Are Leading the Pack appeared first on Millennial Money. Biotechnology companies have received increasing attention from investors, in part because there’s never been a time in all of history when the marriage of technology and biology has been stronger. Advanced scientific technology and research are allowing companies to create treatments and preventions of diseases at an unprecedented pace. This has caused a lot of investors to flock to biotech stocks and will create a $2.4 trillion global biotech industry by 2028.  Even though biotech companies are creating and testing drugs faster than ever, it still takes an average of 12 years for a drug to move from its initial development phase to receiving governmental approval and being used by patients.  But long-term investors know that biotech stocks with more than a handful of approved drugs are more than worth the wait. So let’s take a closer look at seven top biotech stocks that investors need to keep their eyes on.  7 Biotech Stocks for 2021 Here are the top biotech stocks for 2021. Vertex Pharmaceuticals  Bristol-Myers Squibb Co. Novavax, Inc. Sanofi S.A. Axsome Therapeutics, Inc. Moderna  Regeneron Pharmaceuticals Vertex Pharmaceuticals (NASDAQ: VRTX) Vertex Pharmaceuticals (NASDAQ:VRTX)Price: $201.63 (as of close Jun 30, 2021) document.addEventListener(“DOMContentLoaded”, function(event) { Highcharts.stockChart(“stockChart-41dc439c70564e7c9a2ff0e9c47b7d2b”,{rangeSelector:{selected:1},title:{text:”Vertex Pharmaceuticals (NASDAQ:VRTX)Closing Stock Price”},subtitle: {text: “30-Day Historical Data”},navigator: { enabled: false },scrollbar: { enabled: false },credits: { enabled: false },xAxis: { type: “datetime”, labels: { formatter: function() { return Highcharts.dateFormat(“%m %d, %Y”, this.value); }}},colors: [“#118b4e”],rangeSelector : { enabled: false },series:[{name:”NASDAQ:VRTX”,data:[[1622520000000,209.67],[1622606400000,210.38],[1622692800000,211.15],[1622779200000,209.93],[1623038400000,209.16],[1623124800000,211.13],[1623211200000,213.56],[1623297600000,216.77],[1623384000000,193.02],[1623643200000,194.8],[1623729600000,188.97],[1623816000000,187.49],[1623902400000,188.36],[1623988800000,187.85],[1624248000000,187.7],[1624334400000,188.87],[1624420800000,187.52],[1624507200000,191.94],[1624593600000,194.34],[1624852800000,197.82],[1624939200000,196.78],[1625025600000,201.63],],tooltip:{valueDecimals:2,xDateFormat: “%A, %B %e, %Y”}}]}); }); Vertex Pharmaceuticals is best known for its development of cystic fibrosis (CF) treatments. The company has a three-drug combination approved by the U.S. Food and Drug Administration (FDA) to treat CF, making the company the clear leader in the CF treatment space.  And those CF drugs have created a strong financial foundation for the company, helping Vertex’s sales spike 55% in 2020, which contributed to net income skyrocketing 130%.  And Vertex’s management doesn’t think 2020’s momentum will slow down. The company has clinical programs for seven disease areas right now and it said recently that it’ll treat more CF patients and reach new research and development milestones in 2021, which “will fuel our growth this year and for many years to come.”  Like many biotech stocks, Vertex’s stock performance can be a bit volatile from time to time, but over the long term the company’s stock has outperformed the broader market. Over the past five years, Vertex’s stock gained 132% compared to the S&P 500’s 114% increase.  Bristol-Myers Squibb Co. (NYSE: BMY)  Bristol Myers Squibb (NYSE:BMY)Price: $66.82 (as of close Jun 30, 2021) document.addEventListener(“DOMContentLoaded”, function(event) { Highcharts.stockChart(“stockChart-a5dd20f43f6425282b70728db81d3e36”,{rangeSelector:{selected:1},title:{text:”Bristol Myers Squibb (NYSE:BMY)Closing Stock Price”},subtitle: {text: “30-Day Historical Data”},navigator: { enabled: false },scrollbar: { enabled: false },credits: { enabled: false },xAxis: { type: “datetime”, labels: { formatter: function() { return Highcharts.dateFormat(“%m %d, %Y”, this.value); }}},colors: [“#118b4e”],rangeSelector : { enabled: false },series:[{name:”NYSE:BMY”,data:[[1622520000000,65.1],[1622606400000,64.69],[1622692800000,64.8],[1622779200000,64.94],[1623038400000,64.77],[1623124800000,63.7],[1623211200000,65.4],[1623297600000,67.39],[1623384000000,67.34],[1623643200000,67.29],[1623729600000,67.42],[1623816000000,66.92],[1623902400000,66.77],[1623988800000,66.47],[1624248000000,66.83],[1624334400000,65.94],[1624420800000,65.26],[1624507200000,65.85],[1624593600000,66.74],[1624852800000,66.4],[1624939200000,66.27],[1625025600000,66.82],],tooltip:{valueDecimals:2,xDateFormat: “%A, %B %e, %Y”}}]}); }); Bristol-Myers Squibb is a biopharmaceutical giant with more than 120 years of experience. Back in 2019 the company made a big move into the biotech space when it spent an eye-popping $74 billion to buy the biotech company Celgene.  At the time of the purchase, Bristol-Myers Squibb CEO Giovanni Caforio said,  “Together with Celgene, we are creating an innovative biopharma leader, with leading franchises and a deep and broad pipeline that will drive sustainable growth and deliver new options for patients across a range of serious diseases.”   The biopharma company certainly has a lot to be optimistic about. With its acquisition of Celgene two years ago and the more recent purchase of MyoKardia (which makes cardiovascular treatments), Bristol-Myers Squibb continues to expand its reach. The company’s revenue skyrocketed 63% in 2020 to $42.5 billion and income investors will like the fact that this drugmaker pays a dividend yield of 2.94%.  Investors should also note that while this biotech continues to grow quickly, its stock performance hasn’t always kept pace with the broader market. Nevertheless, the company deserves a spot on this list for its leading position in cancer-fighting drugs and its ability to snatch up smaller companies to keep itself growing.    Pick Like A Pro Where to invest $500 right now Lots of new investors take chances on long shots instead of buying shares of great companies. I prefer businesses like Amazon, Netflix, and Apple — they’re all on my best stocks for beginners list. There’s a company that “called” these businesses long before they hit it big. They first recommended Netflix in 2004 at $1.85 per share, Amazon in 2002 at $15.31 per share, and Apple back in the iPod Shuffle era at $4.97 per share. Take a look where they are now. That company: The Motley Fool. For people ready to make investing part of their strategy for financial freedom, take a look at The Motley Fool’s flagship investing service, Stock Advisor. They just announced their top 10 “best buys now” across the entire stock market. Whether you’re starting with $100, $500, or more, you should check out the full details. Email Address Continue Also opt-in to receive Millennial Money! It’s our newsletter devoted to helping you achieve financial freedom. That means you’ll receive new stock ideas, our favorite side hustles, and much more every single week! By submitting your email address, you consent to us keeping you informed about updates to our website and about other products and services that we think might interest you. You can unsubscribe at any time. Please read our Privacy Statement and Terms & Conditions. window.onload = function(event) { if (!document.getElementById(‘ecap-async-js’)) { dataLayer.push({‘event’ : ‘ctaFailed’, ‘failType’ : ‘JS Enqueue Failure’ }); } } Click here to learn more .tmfsa-text-widget .ecap-widget { padding: 0 !important; border-left: 0 !important; } Novavax (Nasdaq: NVAX) Novavax (NASDAQ:NVAX)Price: $212.31 (as of close Jun 30, 2021) document.addEventListener(“DOMContentLoaded”, function(event) { Highcharts.stockChart(“stockChart-90f8c1355c87dd4ccfa5cd513e2200b9”,{rangeSelector:{selected:1},title:{text:”Novavax (NASDAQ:NVAX)Closing Stock Price”},subtitle: {text: “30-Day Historical Data”},navigator: { enabled: false },scrollbar: { enabled: false },credits: { enabled: false },xAxis: { type:

[ad_1] These School-Cool Character Backpacks are so cute! Today only, Zulily has these School-Cool Character Backpack Sets for just $11.99! These sets include lunch bags as well. There are several cute designs to choose from. Shipping starts at $5.99. But if you place one order today, the rest of your orders will ship for FREE through 11:59 p.m. PT tonight! [ad_2] Source link

[ad_1] Walgreens expects lower COVID-19 vaccinations in Q4, shares fall [ad_2] Source link

[ad_1] It was only in March when Twitter announced that it would let you use a security key as your only two-factor authentication method, and on Wednesday, it said via a tweet that the feature is now live. [ad_2] Source link

[ad_1] For a long time, conventional refinances were the norm in product offerings. Now, the focus is on the hot purchase market, and brokers are looking for solutions outside the conventional conforming product box to assist their client base. That’s where Finance of America Mortgage (FAM) TPO’s Two-X Flex suite of proprietary jumbo and non-QM products comes into the picture. “Our products empower brokers to assist more people who would otherwise be shut out of the traditional purchase market,” said Nectar Kalajian, senior vice president, channel leader, TPO. FAM TPO’s Two-X Flex suite comes with additional products to give borrowers even more purchasing or refinancing power, which allows them to qualify for loans based on factors outside of standard requirements. The proprietary loan suite includes: Two-X Flex: a document that allows unconventional borrowers to qualify with two years of income  Two-X Flex Bank: requires no tax returns and enables self-employed borrowers to qualify using bank statements Two-X Flex 1 Year: enables borrowers to qualify  using only one year’s income and Two-X Flex Asset: lets some borrowers qualify based on assets alone and no employment. “At FAM TPO, we pride ourselves on our knowledge of the business, superior customer service, and commitment to improving the lending process, which is why we offer a broad suite of products that enables our broker partners to help more borrowers who might not fit into the conventional lending box,” said Varant Herculian, vice president, digital strategy and innovation, TPO. FAM TPO is a one-stop shop for all types of financial needs. From loan submission to servicing loans, its end-to-end, customer-first lending process is all about ease, quick turn times, and transparency. FAM TPO’s process helps brokers exceed client expectations and get to the closing table with minimal friction. FAM TPO’s account executives work to find brokers the right mortgage wholesale lending solutions for their clients. An AE will walk through the entire lending process and resolve any issues in real-time so brokers can focus on successfully managing their pipeline. By partnering with FAM TPO, brokers get the support, tools, and resources they need to focus on better serving their clients and lose their loans with confidence. “Our broker partners are surrounded by success and have a trusted support system to grow their business,” added Kalajian. “Our cutting-edge technology, knowing we can cater to their borrowers’ diverse range of financial needs, immersive education, and other top-notch resources allow brokers to focus on what’s important – serving their client.” FAM TPO’s diversified lending channels allow broker partners to be at the forefront of the industry in any market condition or environment. “At our core, we are product innovators,” said Omar Cantillo, senior vice president, national operations manager, TPO. “FAM TPO will continue to find ways to assist our broker partners by launching products that allow them to capture more purchase business, help their first-time homebuyers, and assist their past clients as they get ready to retire.” Nectar Kalajian, Senior Vice President, Channel Leader, TPOWith a 40-year history of working in the industry, Nectar Kalajian has overseen sales and operations in retail, wholesale, correspondent, and direct-to-consumer channels throughout her career. Omar Cantillo, Senior Vice President, National Operations Manager, TPOOmar Cantillo has nearly 30 years of leadership experience in finance and executive operations. He has built an entire operation and sales region from the ground up. Varant Herculian, Vice President, Digital Strategy and Innovation, TPOVarant Herculian has spent the last 25 years as a leader in mortgage technology with a focus on implementing and applying technology to drive adoption, and create a better experience for originators and borrowers alike. The post Finance of America’s TPO Two-X Flex suite allows brokers to help borrowers who don’t fit conventional products appeared first on HousingWire. [ad_2] Source link